Skip to main content Accessibility help
×
Home

Clostridium difficile infection in patients with haematological malignant disease: Risk factors, faecal toxins and pathogenic strains

  • S. R. Heard (a1), B. Wren (a1), M. J. Barnett (a2), J. M. Thomas (a3) and S. Tabaqchali (a1)...

Summary

Two hundred and forty-eight patients from shared oncology and general medical wards were prospectively studied over a 6-month period for carriage of Clostridium difficile during an outbreak of clinical disease with an epidemic strain of the organism. Risk factors for infection were assessed. Acute leukaemia and/or its treatment were identified as significantly increasing the risk of infection.

The relationship between the type of C. difficile isolated (as defined by a typing system based on the incorporation of [35S]methionine into bacterial proteins followed by gel electrophoresis), the presence of faecal toxins A and B and clinical symptoms were analysed. Carriage of the epidemic strain, type X, had a significant association with symptoms amongst oncology patients, with two thirds of these patients having detectable faecal toxin A and one third detectable faecal toxin B. During an outbreak of C. difficile-associated disease, typing the organism and assaying for both faecal toxins in symptomatic patients may be of benefit in determining which patients require specific, urgent treatment.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Clostridium difficile infection in patients with haematological malignant disease: Risk factors, faecal toxins and pathogenic strains
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Clostridium difficile infection in patients with haematological malignant disease: Risk factors, faecal toxins and pathogenic strains
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Clostridium difficile infection in patients with haematological malignant disease: Risk factors, faecal toxins and pathogenic strains
      Available formats
      ×

Copyright

References

Hide All
Barclay, F. & Borriello, S. P. (1981). Clostridium difficile and colonization resistance. In Antibiotic-associated-diarrhoea and Colitis (ed. Borriello, S. P.), pp. 8087. The Hague: Martinus Nijhoff.
Bartlett, J. G. & Taylor, N. S. (1984). Antibiotic associated colitis. In Medical Microbiology, vol. I (ed. Easmon, C. S. F., Jelkjaszewicz, J., Brown, M. R. W. and Lambert, P. A.), pp. 148. London: Academic Press.
Burdon, D. W., George, R. H., Mogg, G. A. G., Aram, Y., Johnson, M., Alexander, Williams J. & Keighley, M. R. B. (1981). Faecal toxin and severity of antibiotic-associated pseudomembranous colitis. Journal of Clinical Pathology 32, 548551.
Delmee, M., Homel, M. & Wauters, G. (1985). Serogrouping of Clostridhnn difficile strains by slide agglutination. Journal of Clinical Microbiology 21, 323327.
Fainstein, V., Bodey, G. P. & Fekety, R. (1981). Relapsing pseudomembranous colitis associated with cancer chemotherapy. Journal of Infectious Diseases 143, 865.
George, R. H., Symond, J. M., Dinnock, F., Brown, J. D., Arabi, Y., Shinagawa, N., Keighley, M., Alexander-Williams, J. & Burdon, J. D. W. (1978). Identification of Clostridium difficile as a cause of pseudomembranous colitis. British Medical Journal i, 695.
George, W. L., Sutter, V. L., Citron, D. & Finegold, S. M. (1979). Selective and differential medium for isolation of Clostridium difficile. Journal of Clinical Microbiology 9, 214219.
Heard, S. R., O'Farrell, S., Holland, D., Crook, S., Barnett, M. J. & Tabaqchali, S. (1986). The epidemiology of Clostridium difficile with use of a typing scheme: nosocomial acquisition and cross-infection among immunocompromised patients. Journal of Infectious Diseases 1, 159162.
Holeman, L. V., Cato, E. P. & Moore, W. E. C. (eds) (1977). Anaerobe Laboratory Manual, 4th edn, p. 98. Virginia Polytechnic Institute and State University, Blacksburg, Virginia.
Keighley, B. R. B., Burdon, D. W., Aram, Y., Alexander-Williams, J., Thompson, H., Youngs, D., Johnson, M., Bentley, S. L., George, R. H. & Mogg, G. A. G. (1978). Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. British Medical Journal ii, 16671669.
Kim, K. H., Fekety, R., Batis, D. H., Brown, D., Cudmore, M., Silva, J. & Water, D. (1981). Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. Journal of Infectious Diseases 1, 4250.
Malamou-Ladas, H., O'Farrell, S., Nash, J. Q. & Tabaqchali, S. (1983). Isolation of Clostridium difficile from patients and the environment of hospital wards. Journal of Clinical Pathology 36, 8892.
Morris, J. G., Jarvis, W. R., Nuvey-Montiel, O. L., Towns, M. L., Thompson, P. S., Dowell, V. R., Hill, E. O., Vogler, W. R., Winton, E. F. & Hughes, J. M. (1984). Clostridmm difficile: colonization and toxin production in a cohort of patients with malignant haematological disorders. Archives of Internal Medicine 144, 967969.
Ramplino, A., Warren, R. E., Bevan, C. E., Hoggarth, C. E., Swirsky, D. & Hayhoe, F. G. J. (1985). Clostridium difficile in haematological malignancy. Journal of Clinical Pathology 38, 445451.
Redmond, S. C., Ketley, J. M., Mitchell, T. J., Stephens, J., Burdon, D. W. & Candy, D. C. A. (1985). Detection of Clostridium difficile enterotoxin (toxin A) by ELJSA and other techniques. In Isolation and Identification of Microorganisms of Medical and Veterinary Importance (ed. Collins, C. H. and Grange, J. M.), Society for Applied Bacteriology Technical Series 21, pp. 237249. London: Academic Press.
Rogers, T. R., Petkou, M., Lucas, C., Chung, J. T. N. & Barrett, A. J. (1981). Spread of Clostridium difficile among patients receiving non-absorbable antibiotics for gut decontamination. British Medical Journal 283, 408409.
Slavin, R. E., Dias, M. B. & Soral, R. (1978). Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols. A clinicopathologic study of 33 patients. Cancer 42, 17471759.
Stephens, J., Wilkins, T., Krivan, H., Stiles, B., Carmen, R. & Lyerly, D. (1985). Clostridial toxins active locally in the gastrointestinal tract. In Microbial Toxins and Diarrhoeal Disease (Ciba Foundation Symposium), pp. 230241. London: Pitman.
Tabaqchali, S., O'Farrell, S., Holland, D. & Silman, R. (1984). Typing scheme for Clostridium difficile: its application in clinical and epidemiological studies. Lancet i, 935938.
Tabaqchali, S., O'Farrell, S., Holland, D. & Silman, R. (1986). Method for typing of Clostridium difficile based on PAGE of 35S-Methionine-labelled proteins. Journal of Clinical Microbiology 23, 197198.
Tedesco, F. J. (1982). Pseudomembranous colitis: pathogenesis and therapy. Medical Clinics of North America 3, 655664.
Thompson, G. M., Gilligan, P. H. & Long, S. S. (1982). Interrelationships of stool flora and Clostridium difficile in children with cystic fibrosis. Proceedings of the 22nd International Conference on Antimicrobial Agents and Chemotherapy. Abstract 594.
Viscidi, R., Willey, S. & Bartlett, J. G. (1981). Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 81, 59.
Wilson, K. H. & Sheagren, J. N. (1983). Antagonism of toxigenic Clostridium difficile by nontoxigenic C. difficile. Journal of Infectious Diseases 4, 733735.

Clostridium difficile infection in patients with haematological malignant disease: Risk factors, faecal toxins and pathogenic strains

  • S. R. Heard (a1), B. Wren (a1), M. J. Barnett (a2), J. M. Thomas (a3) and S. Tabaqchali (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed